What can T-cell studies teach us about SARS-CoV-2 immune responses?

T-cells are increasingly recognized for their role in SARS-CoV-2 infection and immunity, and the exploration of cellular responses in the context of COVID-19 is gaining importance for potential improvements in patient management and vaccination guidance.

Recent studies of T-cell responses have demonstrated that they can provide valuable insights into SARS-CoV-2 infection and how our immune system responds to it.

Join Dr. Rory de Vries as he presents the latest findings in the field of SARS-CoV-2-specific T-cell responses after infection or vaccination in immunocompromised populations.

In this live webinar, Dr. de Vries will address current research and discuss potential clinical utilities of T-cell immune monitoring, in the context of natural SARS-CoV-2 infection and vaccination.

Key learning objectives

  • Understand the role of humoral and cellular immunity in COVID-19 natural infection and vaccination contexts
  • Gain insight into the potential role of T-cell responses to emerging variants
  • Become familiar with laboratory methods of cellular immunity assessment and monitoring
  • Understand the potential role of cellular immunity assessment in clinically vulnerable populations

Who should attend?

  • Researchers
  • Physicians
  • Undergraduate and postgraduate students

Certificate of attendance

All webinar participants can request a certificate of attendance, including a learning outcomes summary, for continuing education purposes.

Speakers

Rory de Vries
Rory de Vries
Department of Viroscience, Erasmus Medical Center, Rotterdam, Netherlands
Georgina Wynne Hughes
Georgina Wynne Hughes
Editorial Assistant, SelectScience

Links

Tags